Joe Betts-LaCroix and Retro Biosciences recently raised funding at a $1.8 billion valuation. In his first podcast appearance since the announcement, Joe shares his vision for extending healthy human lifespan and the breakthroughs driving the longevity industry forward.Joe Betts-LaCroix explains why aging is becoming a legitimate scientific target. He shares how new discoveries are turning longevity from speculation into measurable biology.The conversation explores how AI is accelerating research, while highlighting why biology remains one of the hardest problems to solve. Even with smarter models, real-world testing and clinical trials still take time.Joe also discusses Alzheimer's, partial cellular reprogramming, and the future of longevity medicine. He shares why exercise remains the best longevity tool available today and what the next decade could look like for human health.Joe is the CEO of Retro Biosciences and a longtime entrepreneur focused on science and technology. His mission is to extend healthy human lifespan and accelerate breakthroughs in aging research.This episode is brought to you by NADclinic, the go-to destination for longevity and human performance. Check them out at https://nadclinic.com.What You’ll LearnWhy Sam Altman backed Retro BiosciencesThe discovery that changed aging research foreverHow AI is transforming biotech and longevityWhy curing all diseases in 10 years is unlikelyWhat Retro's Alzheimer's programs are targetingWhy biology is harder than most people realizeThe longevity intervention Joe recommends todayHow aging may become a treatable conditionWhat the longevity industry could look like by 2030Joe's vision for the future of human health and AI⏱ Timestamps00:00 Intro00:16 AI's Role in Longevity03:26 Will AI Cure All Diseases?09:41 Why Biology Is So Hard to Solve13:17 Building Technology That Matters15:06 Adding 10 Healthy Years to Life18:08 Inside Retro's Clinical Trial19:31 The Different Types of Longevity Companies22:10 Are We Already in the Singularity?24:46 Why Investors Are Betting on AI Biotech26:15 AI as the New Electricity27:01 The Biggest Risks Facing Longevity30:54 Why More Competition Is Good32:44 Solving Alzheimer's Disease34:26 Aging Biology and Future Therapeutics38:25 The Biggest Aging Myth39:41 The Most Underrated Voices in Longevity40:25 The Best Longevity "Hack"46:13 The Future of Longevity by 203050:49 If Tomorrow Was Your Last Day...Follow Joe:Website: https://www.retro.bio/ LinkedIn: https://www.linkedin.com/in/bettslacroix X: https://x.com/bettslacroix Connect with JulianInstagram: https://www.instagram.com/thebeyondtomorrowpodcast/ Instagram: https://www.instagram.com/juliankissa/ LinkedIn: https://uk.linkedin.com/in/julian-issa Website: www.beyondtomorrowpodcast.com Email: [email protected] Subscribe on Spotify, Apple, and YouTube for more stories from the edge of what is possible.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related